NCT07005362
Recruiting
Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D
Enrollment
36 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT07093476 Phase 3
Recruiting
Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin
Enrollment
171 pts
Location
South Korea
Sponsor
Celltrion